by ASTCT Talks
In this episode of ASTCT Talks, Dr. Rahul Banerjee sits down with Dr. Kenneth Lim and Dr. Yi Lin of Mayo Clinic to discuss a critical and emerging topic in CAR T-cell therapy: delayed...
by David Porter, MD
In this month’s President’s Message, Dr. David Porter highlights the 30th anniversary of ASTCT’s official journal, Transplantation and Cellular Therapy, celebrating its...
by Misty Evans
This spotlight features Misty Evans, DNP, APRN, CPNP-AC, BMTCN, a dedicated leader in transplant and cellular therapy. As an advocate for APPs and ex-officio ASTCT Board member, she shares her...
by ASTCT Advocacy Update
The U.S. Food and Drug Administration (FDA) has announced that Risk Evaluation and Mitigation Strategies (REMS) will no longer be required for BCMA- and CD19-directed autologous CAR T cell...
by ASTCT Talks
In the next installment of ASTCT's Titans of Transplant series, Dr. Shernan Holtan sits down with Dr. Daniel Weisdorf—renowned leader, mentor and pioneer in cellular therapy and...
by David Porter, MD
In this month's President’s Message, Dr. David Porter shares his perspective on the recent dismissal of the CDC’s vaccine advisory committee—and why it matters.